Moore, Mia http://orcid.org/0000-0001-5055-7075
Stansfield, Sarah http://orcid.org/0000-0003-3251-8501
Donnell, Deborah J.
Boily, Marie-Claude
Mitchell, Kate M. http://orcid.org/0000-0002-7050-4787
Anderson, Peter L.
Delany-Moretlwe, Sinead
Bekker, Linda-Gail http://orcid.org/0000-0002-0755-4386
Mgodi, Nyaradzo M.
Celum, Connie L.
Dimitrov, Dobromir http://orcid.org/0000-0002-2842-5436
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (UM1AI068617, UM1AI068617, UM1AI068617, UM1AI068619, UM1AI068617, UM1AI068617, UM1AI068619, UM1AI068619, UM1AI068619, UM1AI068619, UM1AI068619, UM1AI068617)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (UM1AI068617, UM1AI068617, UM1AI068617, UM1AI068619, UM1AI068617, UM1AI068617, UM1AI068619, UM1AI068619, UM1AI068619, UM1AI068619, UM1AI068619, UM1AI068617)
Article History
Received: 1 May 2023
Accepted: 23 August 2023
First Online: 5 October 2023
Competing interests
: P.L.A. has received personal fees from Gilead, ViiV and Merck, as well as research support from Gilead, paid to his institution. L.-G.B. has received honoraria for advisories to Gilead Sciences, Merck (Pty) Ltd, ViiV Healthcare and Janssen; these are not ongoing. K.M.M. has received teaching payments from Pfizer, outside the submitted work. All other authors declare no competing interests.